Correction: ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors

Correction: ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors

Bibliographic Details
Main Authors:	Cristina Balbás-Martínez, María Rodríguez-Pinilla, Ariel Casanova, Orlando Domínguez, David G. Pisano, Gonzalo Gómez, Josep Lloreta, José A. Lorente, Núria Malats, Francisco X. Real
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888214/?tool=EBI

Similar Items

ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
by: Cristina Balbás-Martínez, et al.
Published: (2013-01-01)

Correction: ARID1A Alterations Are Associated with -Wild Type, Poor-Prognosis, Urothelial Bladder Tumors.
by: Cristina Balbás-Martínez, et al.
Published: (2014-01-01)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
by: Alec Kacew, et al.
Published: (2020-11-01)

THE IMMUNOEXPRESSION PROFILE OF FGFR3 AND P53 IN PUNLMP AND UROTHELIAL BLADDER CARCINOMA AT HASAN SADIKIN GENERAL HOSPITAL
by: Sri Suryanti, et al.
Published: (2020-07-01)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
by: Nadia Carvalho Lima, et al.
Published: (2020-05-01)

BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
by: Se Hyun Kim, et al.
Published: (2018-10-01)

Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation
by: Jian-zhou Cao, et al.
Published: (2021-05-01)

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer
by: Hodgson-Garms, M., et al.
Published: (2022)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
by: Ming-Dow Tsay, et al.
Published: (2019-12-01)

Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis
by: Basim Al-Maghrabi, et al.
Published: (2019-01-01)

Grading of urothelial carcinoma of the bladder
by: M. V. Kovylina, et al.
Published: (2017-06-01)

Plasmacytoid urothelial carcinoma of the bladder
by: Meihua Qin, et al.
Published: (2014-01-01)

Chromium in urothelial carcinoma of the bladder
by: Tomasz Golabek, et al.
Published: (2017-12-01)

ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
by: Stefan Garczyk, et al.
Published: (2018-01-01)

Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders
by: Susan K. Keay, et al.
Published: (2014-01-01)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
by: Gang Li, et al.
Published: (2017-08-01)

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
by: Young Saing Kim, et al.
Published: (2018-07-01)

Giant Cell Urothelial Carcinoma of Bladder
by: Harshima Disvini Wijesinghe, et al.
Published: (2021-01-01)

An epidemiologic study on urothelial carcinomas of bladder
by: Ayşenur Keleş, et al.
Published: (2011-09-01)

Urothelial cancers of the bladder in young people
by: Živković Slađana, et al.
Published: (2003-01-01)

Cutaneous metastasis of bladder urothelial carcinoma
by: Osamah Hasan, et al.
Published: (2020-01-01)

Bladder melanosis with concurrent urothelial carcinoma
by: Susanna E. Yau, et al.
Published: (2017-11-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

Urothelial Carcinoma of the Bladder: Radiologic Perspective
by: Dong Won Kim, et al.
Published: (2021-09-01)

The role of the urothelial mucosa in bladder mechanosensation
by: Liaskos, Marina
Published: (2016)

Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
by: Veronika Weyerer, et al.
Published: (2020-03-01)

T375c Mutation of FGFR3 Gene in Bladder Epithelial Cells of Patients with Bladder Cancer
by: M Najafpour pitka, et al.
Published: (2018-07-01)

Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second line setting
by: F. Roghmann, et al.
Published: (2020-07-01)

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
by: Chiara Casadei, et al.
Published: (2019-11-01)

Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.
by: Maciej J Czachorowski, et al.
Published: (2012-01-01)

NESTED VARIANT OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER
by: V. A. Biryukov, et al.
Published: (2014-07-01)

Nested variant of urothelial carcinoma of the urinary bladder
by: Tadashi Terada
Published: (2011-12-01)

CD10 expression in urothelial carcinoma of the bladder
by: Bozkurt Erol R, et al.
Published: (2009-11-01)

Autophagy and urothelial carcinoma of the bladder: A review
by: Thenappan Chandrasekar, et al.
Published: (2016-06-01)

Cost of illness of urothelial bladder cancer in Italy
by: Gerace C, et al.
Published: (2017-07-01)

NESTED VARIANT OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER
by: V. A. Biryukov, et al.
Published: (2014-07-01)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
by: Nada Humayun-Zakaria, et al.
Published: (2019-03-01)

Protein Profiling of Bladder Urothelial Cell Carcinoma.
by: Jinghai Hu, et al.
Published: (2016-01-01)

Urothelial Bladder Cancer with Cavitary Lung Metastases
by: Anil Kurian, et al.
Published: (2011-01-01)

Expression of components of the urothelial cholinergic system in bladder and cultivated primary urothelial cells of the pig
by: Dorothea Leonhäuser, et al.
Published: (2019-07-01)